Most babies posset milk. A meaningful minority of infants reflux to a degree that disturbs feeds, sleep or growth. A smaller minority are reacting to cows' milk protein. The three scenarios can look identical in the first month of life, which is why community pharmacy counter advice for an apparently refluxing infant is a little more structured than it first appears.
NICE guidance separates the questions. NG1 covers gastro-oesophageal reflux disease in children. NG193 covers cows' milk protein allergy. At the pharmacy counter the two overlap, and the practical skill is in recognising which is in play before recommending a product.
What parents usually describe
"She brings milk up after every feed." "He arches his back and screams halfway through bottles." "Her vomit has blood in it." "He has a rash and he's not settling."
The first two descriptions are typical of physiological reflux or gastro-oesophageal reflux disease (GORD). The third and fourth deserve immediate referral — blood in vomit or stool, rash, faltering growth or eczema alongside reflux symptoms are red-flag features for cows' milk protein allergy and should not be managed over the counter.
Physiological reflux: reassurance and simple measures
Physiological reflux in infants is common, peaks around four months and usually resolves by one year. It does not require treatment if the infant is feeding, gaining weight and otherwise well. Community pharmacy advice is largely about reassurance and simple non-pharmacological measures:
- Smaller, more frequent feeds.
- Keeping the infant upright during and after feeds.
- Ensuring feed volumes are not excessive (a 4 kg infant on 200 ml bottles is over-fed).
- Avoiding over-the-counter remedies marketed at "colic" that lack an evidence base for reflux.
Gastro-oesophageal reflux disease
GORD — reflux causing distress, feed refusal, or faltering growth — can be managed stepwise. NICE NG1 recommends, in order of escalation:
- A trial of thickened feeds (for formula-fed infants) or breastfeeding assessment (for breastfed infants).
- A trial of alginate therapy after feeds — Gaviscon Infant is the standard product. It is available over the counter in the UK but is most commonly prescribed. It is not interchangeable with adult Gaviscon.
- If alginate is insufficient and distress or feeding problems persist, trial of a proton pump inhibitor (omeprazole suspension, esomeprazole) or H2 antagonist, prescriber-initiated.
Community pharmacy counselling points for Gaviscon Infant:
- Sachets are dosed by weight and are mixed into the feed, not given separately.
- Each sachet increases sodium load — worth noting for infants already on anti-reflux formula or with sodium-sensitive conditions.
- Do not use with thickened formulas — the two mechanisms overlap and the result is an over-thickened feed that can choke the infant.
Cows' milk protein allergy
NICE NG193 frames CMPA in two categories: IgE-mediated (immediate hypersensitivity, urticaria, angioedema, anaphylaxis) and non-IgE-mediated (delayed, gastrointestinal or skin symptoms). The non-IgE form is the one most often mistaken for plain reflux.
Typical non-IgE CMPA features overlapping with reflux:
- Frequent vomiting or posseting.
- Faltering growth.
- Blood or mucus in stool.
- Persistent eczema or perianal rash.
- Feeding aversion.
First-line management is a therapeutic trial of extensively hydrolysed formula (EHF) for two to four weeks under primary-care oversight, with a subsequent re-challenge to confirm diagnosis. Amino acid formula (AAF) is reserved for EHF non-response, severe reactions or multiple food allergies. EHF and AAF are ACBS-listed prescription products. Community pharmacy should not initiate an EHF trial over the counter — it requires a prescription and, more importantly, a diagnostic framework that can be interpreted afterwards.
Breastfed infants with suspected CMPA are usually managed by the breastfeeding parent adopting a dairy-free diet with appropriate calcium and vitamin D supplementation.
What community pharmacy can safely do
| Scenario | Action |
|---|---|
| Well infant, occasional posseting, gaining weight | Reassure, practical feeding advice, no product |
| Distressed infant, feed-related pain, thriving | Consider thickened feeds or alginate (GP if persistent) |
| Distressed infant with eczema, bloody stool or faltering growth | Refer to GP — do not start alginate alone |
| Acute respiratory distress, angioedema or anaphylaxis | 999 |
| Existing EHF / AAF prescription | Continue as prescribed; do not substitute brand |
Broader sector context
Infant-feeding counter consultations are among the richer interactions in community pharmacy — parents arrive worried and leave with a plan. PharmSee's tracker recorded 1,651 live UK pharmacy vacancies across eleven public sources on 14 April 2026; pressure on the workforce makes these consultations harder to find time for, but they remain among the highest-trust interactions the sector offers.
Caveats
This article is written for adult-facing community pharmacy practice. Specific management decisions — particularly proton pump inhibitor use and formulations for CMPA — are prescriber-initiated. Escalation should always go through the infant's GP or paediatrician.
Sources
- NICE NG1: Gastro-oesophageal reflux disease in children and young people.
- NICE NG193: Cows' milk protein allergy.
- NICE CKS: GORD in children.